title: Challenges in preventing cardiovascular complications in type 2 diabetes in primary care.
abstract: BACKGROUND
  Prevalence of type 2 diabetes mellitus (DM2) continues to increase worldwide. The associated cardiovascular morbidity and mortality are high.
  
  
  OBJECTIVE
  To study daily practice in preventing cardiovascular disease (CVD) in an unselected primary care patient population with DM2, and to study factors influencing the care delivered.
  
  
  METHODS
  Cross-sectional univariate and multivariate analyses of baseline data from a primary care population-based sample of patients with DM2, participating in a shared care project in the Netherlands.
  
  
  RESULTS
  Of 1269 patients invited, 1149 (91%) participated. Hypertension was present in 78% of patients, 63% whom were treated, 41% successfully. Lipid profile abnormalities were present in 51% of patients, 22% of whom were treated, 54% successfully. The treatment rates for lipid profile abnormalities were positively correlated with younger age and the registration of the lipid profile by the GP. For hypertension the treatment rates were higher for patients who were female, of an advanced age, in the presence of CVD, and/or whose blood pressure had been registered by the GP.
  
  
  CONCLUSIONS
  A gap exists between recommended care and the care patients with DM2 in the primary care setting. Diagnosed CVD and the accurate registration with higher treatment rates. Improvement strategies could be directed at primary prevention of CVD and improving the registration of cardiovascular risk factors.
authors.affiliation: Isala Clinics, Weezenlanden Location, Zwolle, Netherlands. l.j.veltmaat@isala.nl
authors.forename: Lielith J
authors.initials: LJ
authors.lastname: Ubink-Veltmaat
authors.forename: Henk J G
authors.initials: HJ
authors.lastname: Bilo
authors.forename: Klaas H
authors.initials: KH
authors.lastname: Groenier
authors.forename: Roel O
authors.initials: RO
authors.lastname: Rischen
authors.forename: Betty
authors.initials: B
authors.lastname: Meyboom-de Jong
mesh_terms: D000367:Age Factors; D000368:Aged; D000704:Analysis of Variance; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D003430:Cross-Sectional Studies; D048909:Diabetes Complications / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D003925:Diabetic Angiopathies / Q000517:prevention & control*; D005194:Family Practice / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006949:Hyperlipidemias / Q000175:diagnosis / Q000188:drug therapy; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009426:Netherlands; D011322:Primary Prevention / Q000379:methods*; D011336:Probability; D018570:Risk Assessment; D012720:Severity of Illness Index; D012737:Sex Factors; D016896:Treatment Outcome
chemical_list: D007004:Hypoglycemic Agents